Show simple item record

dc.contributor.authorSignes Pastor, Antonio J.
dc.contributor.authorDíaz Coto, Susana
dc.contributor.authorMartínez Camblor, Pablo
dc.contributor.authorCarey, Manus
dc.contributor.authorSoler Blasco, Raquel
dc.contributor.authorGarcía Villarino, Miguel
dc.contributor.authorFernández Somoano, Ana
dc.contributor.authorJúlvez, Jordi
dc.contributor.authorCarrasco, Paula
dc.contributor.authorLertxundi Manterola, Aitana
dc.contributor.authorSanta Marina Rodríguez, Loreto
dc.contributor.authorCasas, Maribel
dc.contributor.authorMeharg, Andrew A.
dc.contributor.authorKaragas, Margaret R.
dc.contributor.authorVioque, Jesús
dc.date.accessioned2023-05-17T17:22:18Z
dc.date.available2023-05-17T17:22:18Z
dc.date.issued2022-09
dc.identifier.citationPLoS ONE 17(9) : (2022) // Article ID e0274215es_ES
dc.identifier.issn1932-6203
dc.identifier.urihttp://hdl.handle.net/10810/61149
dc.description.abstractIngested inorganic arsenic (iAs) is a human carcinogen that is also linked to other adverse health effects, such as respiratory outcomes. Yet, among populations consuming low-arsenic drinking water, the impact of iAs exposure on childhood respiratory health is still uncertain. For a Spanish child study cohort (INfancia y Medio Ambiente—INMA), low-arsenic drinking water is usually available and ingestion of iAs from food is considered the major source of exposure. Here, we explored the association between iAs exposure and children’s respiratory outcomes assessed at 4 and 7 years of age (n = 400). The summation of 4-year-old children’s urinary iAs, monomethylarsonic acid (MMA), and dimethylarsinic acid (DMA) was used as a biomarker of iAs exposure (∑As) (median of 4.92 μg/L). Children’s occurrence of asthma, eczema, sneeze, wheeze, and medication for asthma and wheeze at each assessment time point (i.e., 4- and 7-year) was assessed with maternal interviewer-led questionnaires. Crude and adjusted Poisson regression models using Generalized Estimating Equation (GEE) were performed to account for the association between natural logarithm transformed (ln) urinary ∑As in μg/L at 4 years and repeated assessments of respiratory symptoms at 4 and 7 years of age. The covariates included in the models were child sex, maternal smoking status, maternal level of education, sub-cohort, and children’s consumption of vegetables, fruits, and fish/seafood. The GEE—splines function using Poisson regression showed an increased trend of the overall expected counts of respiratory symptoms with high urinary ∑As. The adjusted expected counts (95% confidence intervals) at ln-transformed urinary ∑As 1.57 (average concentration) and 4.00 (99th percentile concentration) were 0.63 (0.36, 1.10) and 1.33 (0.61, 2.89), respectively. These exploratory findings suggest that even relatively low-iAs exposure levels, relevant to the Spanish and other populations, may relate to an increased number of respiratory symptoms during childhood.es_ES
dc.description.sponsorshipi) CIDEGENT/2020/050 (Antonio J. Signes-Pastor); ii) P01ES022832, RD83544201, and R25CA134286 (Margaret R. Karagas); iii) MS15/0025, MSII20/0006, CP15/0025, FIS-FSE: 17/00260, FIS-FEDER: 16/1288, 19/1338; iv) CIBERESP (Miguel García-Villarino PhD-employment-contract and fellowship for short stays abroad-2019), Instituto de Salud Carlos III, ISCIII-FEDER: PI04/2018, PI09/02311, PI13/02429, PI18/00909; Obra Social Cajastur/Fundación Liberbank, and Universidad de Oviedo; v) Instituto de Salud Carlos III, ISCIII-FEDER: PI07/0314 and PI11/01007; vi) Instituto de Salud Carlos III (FIS-PI09/00090 and FIS-PI18/01142 incl. FEDER funds), CIBERESP, Department of Health of the Basque Government (2013111089, 2015111065), Provincial Government of Gipuzkoa (DFG15/221) and annual agreements with the municipalities of the study area (Zumarraga, Urretxu, Legazpi, Azkoitia y Azpeitia y Beasain), and vii) Miguel Servet fellowship (CP16/00128) funded by Instituto de Salud Carlos III and cofounded by European Social Fund “Investing in your future” (Maribel Casas). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.es_ES
dc.language.isoenges_ES
dc.publisherPublic Library Sciencees_ES
dc.rightsinfo:eu-repo/semantics/openAccesses_ES
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es/*
dc.titleArsenic exposure and respiratory outcomes during childhood in the INMA studyes_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.holder© 2022 Signes-Pastor et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.es_ES
dc.rights.holderAtribución 3.0 España*
dc.relation.publisherversionhttps://journals.plos.org/plosone/article?id=10.1371/journal.pone.0274215es_ES
dc.identifier.doi10.1371/journal.pone.0274215
dc.departamentoesMedicina preventiva y salud públicaes_ES
dc.departamentoeuPrebentzio medikuntza eta osasun publikoaes_ES


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record

© 2022 Signes-Pastor et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Except where otherwise noted, this item's license is described as © 2022 Signes-Pastor et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.